Which has better valuation & earnings, BLLN or CDNA?

Billiontoone has higher earnings, but lower revenue than CareDx. CareDx is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $354.54M 17.00 $7.45M $0.55 238.32 CareDx $379.80M 5.18 -$21.35M -$0.16 N/A

Does the media refer more to BLLN or CDNA?

In the previous week, CareDx had 11 more articles in the media than Billiontoone. MarketBeat recorded 14 mentions for CareDx and 3 mentions for Billiontoone. CareDx's average media sentiment score of 0.77 beat Billiontoone's score of 0.57 indicating that CareDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CareDx 5 Very Positive mention(s) 6 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, SHC or CDNA?

Sotera Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sotera Health $1.16B 4.27 $77.94M $0.41 42.48 CareDx $379.80M 5.18 -$21.35M -$0.16 N/A

Is SHC or CDNA more profitable?

Sotera Health has a net margin of 9.91% compared to CareDx's net margin of -2.01%. Sotera Health's return on equity of 39.73% beat CareDx's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 9.91% 39.73% 7.05% CareDx -2.01% -2.65% -1.96%

Does the media prefer SHC or CDNA?

In the previous week, CareDx had 11 more articles in the media than Sotera Health. MarketBeat recorded 14 mentions for CareDx and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.73 beat CareDx's score of 0.77 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive CareDx 5 Very Positive mention(s) 6 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, CELC or CDNA?

CareDx has higher revenue and earnings than Celcuity. CareDx is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celcuity N/A N/A -$177.04M -$3.90 N/A CareDx $379.80M 5.18 -$21.35M -$0.16 N/A

Is CELC or CDNA more profitable?

Celcuity has a net margin of 0.00% compared to CareDx's net margin of -2.01%. CareDx's return on equity of -2.65% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% CareDx -2.01% -2.65% -1.96%

Does the media favor CELC or CDNA?

In the previous week, Celcuity had 14 more articles in the media than CareDx. MarketBeat recorded 28 mentions for Celcuity and 14 mentions for CareDx. CareDx's average media sentiment score of 0.77 beat Celcuity's score of 0.05 indicating that CareDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 7 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral CareDx 5 Very Positive mention(s) 6 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, CDNA or RDNT?

RadNet has higher revenue and earnings than CareDx. RadNet is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareDx $379.80M 5.18 -$21.35M -$0.16 N/A RadNet $2.04B 2.38 -$18.65M -$0.18 N/A

Is CDNA or RDNT more profitable?

RadNet has a net margin of -0.66% compared to CareDx's net margin of -2.01%. RadNet's return on equity of 2.77% beat CareDx's return on equity. Company Net Margins Return on Equity Return on Assets CareDx -2.01% -2.65% -1.96% RadNet -0.66% 2.77% 0.97%

Does the media refer more to CDNA or RDNT?

In the previous week, CareDx had 6 more articles in the media than RadNet. MarketBeat recorded 14 mentions for CareDx and 8 mentions for RadNet. RadNet's average media sentiment score of 0.92 beat CareDx's score of 0.77 indicating that RadNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 5 Very Positive mention(s) 6 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CAI or CDNA?

In the previous week, CareDx had 8 more articles in the media than Caris Life Sciences. MarketBeat recorded 14 mentions for CareDx and 6 mentions for Caris Life Sciences. CareDx's average media sentiment score of 0.77 beat Caris Life Sciences' score of 0.50 indicating that CareDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive CareDx 5 Very Positive mention(s) 6 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

CareDx (CDNA) Competitors

$38.10 -0.27 (-0.70%)

As of 11:25 AM Eastern

Compare

CDNA vs. BLLN, SHC, CELC, RDNT, and CAI

Should you buy CareDx stock or one of its competitors? MarketBeat compares CareDx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CareDx include Billiontoone (BLLN), Sotera Health (SHC), Celcuity (CELC), RadNet (RDNT), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does CareDx compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and CareDx (NASDAQ:CDNA) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

In the previous week, CareDx had 11 more articles in the media than Billiontoone. MarketBeat recorded 14 mentions for CareDx and 3 mentions for Billiontoone. CareDx's average media sentiment score of 0.77 beat Billiontoone's score of 0.57 indicating that CareDx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CareDx	5 Very Positive mention(s)	6 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone has higher earnings, but lower revenue than CareDx. CareDx is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$354.54M	17.00	$7.45M	$0.55	238.32
CareDx	$379.80M	5.18	-$21.35M	-$0.16	N/A

Billiontoone currently has a consensus target price of $126.00, suggesting a potential downside of 3.87%. CareDx has a consensus target price of $33.67, suggesting a potential downside of 11.64%. Given Billiontoone's stronger consensus rating and higher probable upside, equities research analysts plainly believe Billiontoone is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Billiontoone has a net margin of 0.00% compared to CareDx's net margin of -2.01%. Billiontoone's return on equity of 0.00% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
CareDx	-2.01%	-2.65%	-1.96%

Summary

Billiontoone beats CareDx on 10 of the 13 factors compared between the two stocks.

How does CareDx compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

Sotera Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.27	$77.94M	$0.41	42.48
CareDx	$379.80M	5.18	-$21.35M	-$0.16	N/A

Sotera Health has a net margin of 9.91% compared to CareDx's net margin of -2.01%. Sotera Health's return on equity of 39.73% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
CareDx	-2.01%	-2.65%	-1.96%

Sotera Health currently has a consensus target price of $20.25, suggesting a potential upside of 16.28%. CareDx has a consensus target price of $33.67, suggesting a potential downside of 11.64%. Given Sotera Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Sotera Health is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

91.0% of Sotera Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by insiders. Comparatively, 2.4% of CareDx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Sotera Health has a beta of 1.76, indicating that its stock price is 76% more volatile than the broader market. Comparatively, CareDx has a beta of 2.43, indicating that its stock price is 143% more volatile than the broader market.

In the previous week, CareDx had 11 more articles in the media than Sotera Health. MarketBeat recorded 14 mentions for CareDx and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.73 beat CareDx's score of 0.77 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
CareDx	5 Very Positive mention(s)	6 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sotera Health beats CareDx on 13 of the 16 factors compared between the two stocks.

How does CareDx compare to Celcuity?

Celcuity (NASDAQ:CELC) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

Celcuity has a beta of 0.16, indicating that its stock price is 84% less volatile than the broader market. Comparatively, CareDx has a beta of 2.43, indicating that its stock price is 143% more volatile than the broader market.

CareDx has higher revenue and earnings than Celcuity. CareDx is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
CareDx	$379.80M	5.18	-$21.35M	-$0.16	N/A

In the previous week, Celcuity had 14 more articles in the media than CareDx. MarketBeat recorded 28 mentions for Celcuity and 14 mentions for CareDx. CareDx's average media sentiment score of 0.77 beat Celcuity's score of 0.05 indicating that CareDx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	7 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral
CareDx	5 Very Positive mention(s)	6 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Celcuity currently has a consensus price target of $155.18, indicating a potential upside of 71.59%. CareDx has a consensus price target of $33.67, indicating a potential downside of 11.64%. Given Celcuity's stronger consensus rating and higher possible upside, analysts clearly believe Celcuity is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Celcuity has a net margin of 0.00% compared to CareDx's net margin of -2.01%. CareDx's return on equity of -2.65% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
CareDx	-2.01%	-2.65%	-1.96%

63.3% of Celcuity shares are held by institutional investors. 13.3% of Celcuity shares are held by insiders. Comparatively, 2.4% of CareDx shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Celcuity beats CareDx on 8 of the 15 factors compared between the two stocks.

How does CareDx compare to RadNet?

CareDx (NASDAQ:CDNA) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

In the previous week, CareDx had 6 more articles in the media than RadNet. MarketBeat recorded 14 mentions for CareDx and 8 mentions for RadNet. RadNet's average media sentiment score of 0.92 beat CareDx's score of 0.77 indicating that RadNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareDx	5 Very Positive mention(s)	6 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has a net margin of -0.66% compared to CareDx's net margin of -2.01%. RadNet's return on equity of 2.77% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-2.01%	-2.65%	-1.96%
RadNet	-0.66%	2.77%	0.97%

CareDx currently has a consensus target price of $33.67, indicating a potential downside of 11.64%. RadNet has a consensus target price of $87.43, indicating a potential upside of 41.86%. Given RadNet's stronger consensus rating and higher possible upside, analysts plainly believe RadNet is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80

RadNet has higher revenue and earnings than CareDx. RadNet is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$379.80M	5.18	-$21.35M	-$0.16	N/A
RadNet	$2.04B	2.38	-$18.65M	-$0.18	N/A

77.9% of RadNet shares are owned by institutional investors. 2.4% of CareDx shares are owned by insiders. Comparatively, 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

CareDx has a beta of 2.43, indicating that its share price is 143% more volatile than the broader market. Comparatively, RadNet has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

Summary

RadNet beats CareDx on 12 of the 17 factors compared between the two stocks.

How does CareDx compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and CareDx (NASDAQ:CDNA) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Caris Life Sciences presently has a consensus price target of $26.11, suggesting a potential upside of 65.89%. CareDx has a consensus price target of $33.67, suggesting a potential downside of 11.64%. Given Caris Life Sciences' stronger consensus rating and higher possible upside, research analysts clearly believe Caris Life Sciences is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, CareDx had 8 more articles in the media than Caris Life Sciences. MarketBeat recorded 14 mentions for CareDx and 6 mentions for Caris Life Sciences. CareDx's average media sentiment score of 0.77 beat Caris Life Sciences' score of 0.50 indicating that CareDx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
CareDx	5 Very Positive mention(s)	6 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CareDx has higher revenue and earnings than Caris Life Sciences. CareDx is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$348.89M	12.75	-$68.09M	-$7.61	N/A
CareDx	$379.80M	5.18	-$21.35M	-$0.16	N/A

Caris Life Sciences has a net margin of 3.75% compared to CareDx's net margin of -2.01%. Caris Life Sciences' return on equity of 98.28% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
CareDx	-2.01%	-2.65%	-1.96%

Summary

Caris Life Sciences beats CareDx on 8 of the 13 factors compared between the two stocks.

Get CareDx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CDNA vs. The Competition

Export

Metric	CareDx	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.97B	$9.36B	$6.80B	$12.40B
Dividend Yield	N/A	1.60%	2.67%	9.39%
P/E Ratio	-238.02	26.56	27.08	24.12
Price / Sales	5.18	19.09	516.47	92.58
Price / Cash	N/A	15.03	26.68	47.25
Price / Book	6.47	6.19	10.63	6.23
Net Income	-$21.35M	$179.69M	$3.60B	$331.53M
7 Day Performance	31.70%	-1.16%	-1.08%	-1.30%
1 Month Performance	45.53%	4.70%	1.28%	-1.40%
1 Year Performance	198.82%	13.90%	24.71%	18.15%

CareDx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CDNA CareDx	2.0462 of 5 stars	$38.10 -0.7%	$33.67 -11.6%	+222.2%	$1.97B	$379.80M	N/A	740
BLLN Billiontoone	1.9145 of 5 stars	$123.25 -2.8%	$126.00 +2.2%	N/A	$5.83B	$305.11M	224.09	620
SHC Sotera Health	3.6484 of 5 stars	$18.17 -1.4%	$20.25 +11.4%	+57.5%	$5.25B	$1.16B	44.32	3,000	News Coverage Positive News
CELC Celcuity	3.3843 of 5 stars	$103.79 -3.5%	$152.09 +46.5%	+547.5%	$5.25B	N/A	N/A	40
RDNT RadNet	3.6494 of 5 stars	$63.31 -3.5%	$87.43 +38.1%	+5.5%	$5.16B	$2.04B	N/A	11,264	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CDNA) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareDx (CDNA) Competitors